Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19232212 | 0.90 | HRH1 (0.59) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| SCHEMBL31140119 | 0.88 | — | — | |
| SCHEMBL24490 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL945712 | 0.86 | HRH1 (0.59) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| Water SCHEMBL7380191 | 0.86 | HRH1 (0.59) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| Methane SCHEMBL3061813 | 0.86 | HRH1 (0.59) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| Acetic Acid SCHEMBL28615313 | 0.85 | CYP1A2 (0.54) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| Acetic Acid SCHEMBL28068324 | 0.84 | CYP1A2 (0.53) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| Piconol SCHEMBL11480832 | 0.82 | HRH1 (0.55) | HRH1HRH3LMNAALDH1A1TAAR1 | |
| SCHEMBL31438870 | 0.81 | HRH1 (0.53) | HRH1HRH3LMNAALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1672961-B1 | COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | MITSUBISHI CHEM CORP (JP) | 2014-12-03 | — | — | EP | disclosed |
| EP-2592905-B1 | Compound, charge transporting material and organic electroluminescent element | MITSUBISHI CHEM CORP (JP) | 2014-11-12 | — | — | EP | disclosed |
| EP-2592905-A1 | Compound, charge transporting material and organic electroluminescent element | Mitsubishi Chemical Corporation (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-7777043-B2 | Compound, charge transporting material and organic electroluminescent element | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-08-17 | — | — | US | disclosed |
| US-20060186796-A1 | Compound, charge transporting material and organic electroluminescent element | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-08-24 | — | — | US | disclosed |
| EP-1672961-A1 | COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | Mitsubishi Chemical Corporation (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060186796-A1 | Compound, charge transporting material and organic electroluminescent element | SLCO4C1, SLC26A3, SLC7A5 | HRH1 2239/4885NPSR1 4086/4885HRH3 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.